SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001079973-24-000714
Filing Date
2024-05-15
Accepted
2024-05-15 08:46:59
Documents
52
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pktx_10q.htm   iXBRL 10-Q 392022
2 EXHIBIT 31.1 ex31x1.htm EX-31.1 10312
3 EXHIBIT 31.2 ex31x2.htm EX-31.2 10204
4 EXHIBIT32 ex32.htm EX-32 5414
  Complete submission text file 0001079973-24-000714.txt   2539677

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE pktx-20240331.xsd EX-101.SCH 23212
6 XBRL CALCULATION FILE pktx-20240331_cal.xml EX-101.CAL 23600
7 XBRL DEFINITION FILE pktx-20240331_def.xml EX-101.DEF 82080
8 XBRL LABEL FILE pktx-20240331_lab.xml EX-101.LAB 206971
9 XBRL PRESENTATION FILE pktx-20240331_pre.xml EX-101.PRE 176930
55 EXTRACTED XBRL INSTANCE DOCUMENT pktx_10q_htm.xml XML 270610
Mailing Address 109 W. MAIN ST. DALTON OH 44618
Business Address 109 W. MAIN ST. DALTON OH 44618 330-445-4971
ProtoKinetix, Inc. (Filer) CIK: 0001128189 (see all company filings)

IRS No.: 943355026 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-32917 | Film No.: 24947392
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)